Neuromuscular Blockade: Difference between revisions

Jump to navigation Jump to search
no edit summary
No edit summary
No edit summary
Line 11: Line 11:


[https://pubmed.ncbi.nlm.nih.gov/31584918/ Retrospective Analysis of the Safety and Efficacy of Sugammadex Versus Neostigmine for the Reversal of Neuromuscular Blockade in Children]
[https://pubmed.ncbi.nlm.nih.gov/31584918/ Retrospective Analysis of the Safety and Efficacy of Sugammadex Versus Neostigmine for the Reversal of Neuromuscular Blockade in Children]


[https://pubmed.ncbi.nlm.nih.gov/10983014/ Neuromuscular blockade in children]
[https://pubmed.ncbi.nlm.nih.gov/10983014/ Neuromuscular blockade in children]
Line 17: Line 18:


[[TYK6 |Test Your Knowledge]]: unique advantage of rocuronium
[[TYK6 |Test Your Knowledge]]: unique advantage of rocuronium


[https://pubmed.ncbi.nlm.nih.gov/21474022/ Assessment of neuromuscular blockade in children at the time of block reversal and the removal of the endotracheal tube]
[https://pubmed.ncbi.nlm.nih.gov/21474022/ Assessment of neuromuscular blockade in children at the time of block reversal and the removal of the endotracheal tube]

Navigation menu